Lifevantage Corp Files 2024 Annual Report
Ticker: LFVN · Form: 10-K · Filed: Aug 28, 2024 · CIK: 849146
| Field | Detail |
|---|---|
| Company | Lifevantage Corp (LFVN) |
| Form Type | 10-K |
| Filed Date | Aug 28, 2024 |
| Risk Level | low |
| Pages | 14 |
| Reading Time | 17 min |
| Key Dollar Amounts | $0.0001, $6.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
Lifevantage filed its 2024 10-K. Check financials for the year ending June 30.
AI Summary
Lifevantage Corp filed its 10-K for the fiscal year ending June 30, 2024, reporting on its business operations. The company, previously known as Lifeline Therapeutics, Inc., operates in the pharmaceutical preparations sector. Its principal executive offices are located at 3300 Triumph Blvd, Suite 700, Lehi, UT 84043.
Why It Matters
This filing provides a comprehensive overview of Lifevantage Corp's financial performance and business activities for the past fiscal year, crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual financial filing with no immediate red flags or significant new risks highlighted in the provided snippet.
Key Players & Entities
- Lifevantage Corp (company) — Filer of the 10-K
- 20240630 (date) — Fiscal year end
- 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 (location) — Company business and mailing address
- Lifeline Therapeutics, Inc. (company) — Former company name
FAQ
What is Lifevantage Corp's primary business sector?
Lifevantage Corp operates in the Pharmaceutical Preparations sector, with SIC code 2834.
When did Lifevantage Corp's fiscal year end for this filing?
The fiscal year end for this filing was June 30, 2024.
What was Lifevantage Corp's previous company name?
Lifevantage Corp was formerly known as Lifeline Therapeutics, Inc., Yaaak River Resources Inc, and Andraplex Corp.
Where is Lifevantage Corp headquartered?
Lifevantage Corp's business and mailing address is 3300 Triumph Blvd, Suite 700, Lehi, UT 84043.
What is the SEC file number for Lifevantage Corp's 10-K filing?
The SEC file number for this 10-K filing is 001-35647.
Filing Stats: 4,271 words · 17 min read · ~14 pages · Grade level 17.2 · Accepted 2024-08-28 16:05:36
Key Financial Figures
- $0.0001 — ) of the Act: Common Stock, par value $0.0001 LFVN The Nasdaq Stock Market LLC Title
- $6.00 — ion, based on a closing market price of $6.00 per share. The number of shares of com
Filing Documents
- lfvn-20240630.htm (10-K) — 1641KB
- a2017ltipamended.htm (EX-10.3) — 165KB
- ex109keyexecutivebenefit.htm (EX-10.9) — 45KB
- ex211listofsubsidiaries063.htm (EX-21.1) — 12KB
- ex231deloitteconsent063020.htm (EX-23.1) — 2KB
- ex311ceosec302certificatio.htm (EX-31.1) — 10KB
- ex312cfosec302certificatio.htm (EX-31.2) — 10KB
- ex321ceosec906certificatio.htm (EX-32.1) — 4KB
- ex322cfosec906certificatio.htm (EX-32.2) — 4KB
- clawbackpolicy.htm (EX-97.1) — 48KB
- ex109keyexecutivebenefit001.jpg (GRAPHIC) — 252KB
- ex109keyexecutivebenefit002.jpg (GRAPHIC) — 217KB
- ex109keyexecutivebenefit003.jpg (GRAPHIC) — 248KB
- ex109keyexecutivebenefit004.jpg (GRAPHIC) — 286KB
- ex109keyexecutivebenefit005.jpg (GRAPHIC) — 307KB
- ex109keyexecutivebenefit006.jpg (GRAPHIC) — 309KB
- ex109keyexecutivebenefit007.jpg (GRAPHIC) — 278KB
- ex109keyexecutivebenefit008.jpg (GRAPHIC) — 257KB
- ex109keyexecutivebenefit009.jpg (GRAPHIC) — 240KB
- ex109keyexecutivebenefit010.jpg (GRAPHIC) — 306KB
- ex109keyexecutivebenefit011.jpg (GRAPHIC) — 46KB
- ex109keyexecutivebenefit012.jpg (GRAPHIC) — 29KB
- 0000849146-24-000073.txt ( ) — 11969KB
- lfvn-20240630.xsd (EX-101.SCH) — 45KB
- lfvn-20240630_cal.xml (EX-101.CAL) — 94KB
- lfvn-20240630_def.xml (EX-101.DEF) — 207KB
- lfvn-20240630_lab.xml (EX-101.LAB) — 700KB
- lfvn-20240630_pre.xml (EX-101.PRE) — 500KB
- lfvn-20240630_htm.xml (XML) — 954KB
Risk Factors
Item 1A. Risk Factors 24
Unresolved Staff Comments
Item 1B. Unresolved Staff Comments 42
C . C ybersecurity
Item 1 C . C ybersecurity 42
Properties
Item 2. Properties 42
Legal Proceedings
Item 3. Legal Proceedings 43
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 43 PART II
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 43
Reserved
Item 6. Reserved 44
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 44
Quantitative and Qualitative Disclosures About Market Risk
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 54
Financial Statements and Supplementary Data
Item 8. Financial Statements and Supplementary Data 54
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 54
Controls and Procedures
Item 9A. Controls and Procedures 54
Other Information
Item 9B. Other Information 55
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 55 PART III
Directors, Executive Officers and Corporate Governance
Item 10. Directors, Executive Officers and Corporate Governance 55
Executive Compensation
Item 11. Executive Compensation 55
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 56
Certain Relationships and Related Transactions, and Director Independence
Item 13. Certain Relationships and Related Transactions, and Director Independence 56
Principal Accountant Fees and Services
Item 14. Principal Accountant Fees and Services 56 PART IV
Exhibits, Financial Statement Schedules
Item 15. Exhibits, Financial Statement Schedules 56
Signatures
Signatures 59 5 PART I
— BUSINESS
ITEM 1 — BUSINESS Overview LifeVantage Corporation (the "Company," "LifeVantage," "we," "us," or "our") is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. LifeVantage is dedicated to helping people achieve their health, wellness and financial goals. We provide quality, scientifically validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to our independent consultants. We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. We also sell our products in a number of countries to customers for personal consumption only. We engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. Our line of scientifically validated dietary supplements includes our flagship Protandim family of products, LifeVantage Omega+, ProBio, IC Bright , Rise AM, Reset PM, D3+, Daily Wellness, and PhysIQ Fat Burn and Prebiotic dietary supplements. TrueScience is our line of skin and hair care products and Liquid Collagen. We also market and sell Petandim , our companion pet supplement formulated to combat oxidative stress in dogs; and AXIO , our nootropic energy drink mixes. We were incorporated in Colorado in June 1988 under the name Andraplex Corporation. We changed our corporate name to Yaak River Resources, Inc. in January 1992 and subsequently changed it again in October 2004 to Lifeline Therapeutics, Inc. In October 2004 and March 2005, we acquired all of the outstanding common stock of Lifeline Nutraceuticals Corporation. In November 2006, we changed our name to LifeVantage Corporation.